Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1990 1
1991 2
1994 1
1995 5
1996 3
1997 2
1999 6
2000 11
2001 6
2002 7
2003 7
2004 2
2005 6
2006 9
2007 6
2008 4
2009 6
2010 9
2011 5
2012 6
2013 11
2014 13
2015 8
2016 8
2017 5
2018 4
2019 7
2020 6
2021 6
2022 8
2023 8
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

169 results

Results by year

Filters applied: . Clear all
Page 1
Altered glycosylation of IgG4 promotes lectin complement pathway activation in anti-PLA2R1-associated membranous nephropathy.
Haddad G, Lorenzen JM, Ma H, de Haan N, Seeger H, Zaghrini C, Brandt S, Kölling M, Wegmann U, Kiss B, Pál G, Gál P, Wüthrich RP, Wuhrer M, Beck LH, Salant DJ, Lambeau G, Kistler AD. Haddad G, et al. Among authors: lambeau g. J Clin Invest. 2021 Mar 1;131(5):e140453. doi: 10.1172/JCI140453. J Clin Invest. 2021. PMID: 33351779 Free PMC article.
High-Dose Rituximab and Early Remission in PLA2R1-Related Membranous Nephropathy.
Seitz-Polski B, Dahan K, Debiec H, Rousseau A, Andreani M, Zaghrini C, Ticchioni M, Rosenthal A, Benzaken S, Bernard G, Lambeau G, Ronco P, Esnault VLM. Seitz-Polski B, et al. Among authors: lambeau g. Clin J Am Soc Nephrol. 2019 Aug 7;14(8):1173-1182. doi: 10.2215/CJN.11791018. Epub 2019 Jul 24. Clin J Am Soc Nephrol. 2019. PMID: 31340979 Free PMC article. Clinical Trial.
Mayo Clinic consensus report on membranous nephropathy: proposal for a novel classification.
Sethi S, Beck LH Jr, Glassock RJ, Haas M, De Vriese AS, Caza TN, Hoxha E, Lambeau G, Tomas NM, Madden B, Debiec H, D'Agati VD, Alexander MP, Amer H, Appel GB, Barbour SJ, Caravaca-Fontan F, Cattran DC, Casal Moura M, D'Avila DO, Eick RG, Garovic VD, Greene EL, Herrera Hernandez LP, Jennette JC, Lieske JC, Markowitz GS, Nath KA, Nasr SH, Nast CC, Pani A, Praga M, Remuzzi G, Rennke HG, Ruggenenti P, Roccatello D, Soler MJ, Specks U, Stahl RAK, Singh RD, Theis JD, Velosa JA, Wetzels JFM, Winearls CG, Yandian F, Zand L, Ronco P, Fervenza FC. Sethi S, et al. Among authors: lambeau g. Kidney Int. 2023 Dec;104(6):1092-1102. doi: 10.1016/j.kint.2023.06.032. Epub 2023 Oct 5. Kidney Int. 2023. PMID: 37795587 Free article.
The STARMEN trial indicates that alternating treatment with corticosteroids and cyclophosphamide is superior to sequential treatment with tacrolimus and rituximab in primary membranous nephropathy.
Fernández-Juárez G, Rojas-Rivera J, Logt AV, Justino J, Sevillano A, Caravaca-Fontán F, Ávila A, Rabasco C, Cabello V, Varela A, Díez M, Martín-Reyes G, Diezhandino MG, Quintana LF, Agraz I, Gómez-Martino JR, Cao M, Rodríguez-Moreno A, Rivas B, Galeano C, Bonet J, Romera A, Shabaka A, Plaisier E, Espinosa M, Egido J, Segarra A, Lambeau G, Ronco P, Wetzels J, Praga M; STARMEN Investigators. Fernández-Juárez G, et al. Among authors: lambeau g. Kidney Int. 2021 Apr;99(4):986-998. doi: 10.1016/j.kint.2020.10.014. Epub 2020 Nov 7. Kidney Int. 2021. PMID: 33166580 Free article. Clinical Trial.
[Membranous nephropathy: Pathophysiology and natural history].
Seitz-Polski B, Lambeau G, Esnault V. Seitz-Polski B, et al. Among authors: lambeau g. Nephrol Ther. 2017 Apr;13 Suppl 1:S75-S81. doi: 10.1016/j.nephro.2017.01.012. Nephrol Ther. 2017. PMID: 28577747 Review. French.
Mayo Clinic Consensus Report on Membranous Nephropathy: Proposal for a Novel Classification.
Sethi S, Beck LH Jr, Glassock RJ, Haas M, De Vriese AS, Caza TN, Hoxha E, Lambeau G, Tomas NM, Madden B, Debiec H, D'Agati VD, Alexander MP, Amer H, Appel GB, Barbour SJ, Caravaca-Fontan F, Cattran DC, Casal Moura M, D'Avila DO, Eick RG, Garovic VD, Greene EL, Herrera Hernandez LP, Jennette JC, Lieske JC, Markowitz GS, Nath KA, Nasr SH, Nast CC, Pani A, Praga M, Remuzzi G, Rennke HG, Ruggenenti P, Roccatello D, Soler MJ, Specks U, Stahl RAK, Singh RD, Theis JD, Velosa JA, Wetzels JFM, Winearls CG, Yandian F, Zand L, Ronco P, Fervenza FC. Sethi S, et al. Among authors: lambeau g. Mayo Clin Proc. 2023 Nov;98(11):1671-1684. doi: 10.1016/j.mayocp.2023.08.006. Epub 2023 Oct 5. Mayo Clin Proc. 2023. PMID: 37804268 Free article.
Lipid droplets control mitogenic lipid mediator production in human cancer cells.
Jovičić EJ, Janež AP, Eichmann TO, Koren Š, Brglez V, Jordan PM, Gerstmeier J, Lainšček D, Golob-Urbanc A, Jerala R, Lambeau G, Werz O, Zimmermann R, Petan T. Jovičić EJ, et al. Among authors: lambeau g. Mol Metab. 2023 Oct;76:101791. doi: 10.1016/j.molmet.2023.101791. Epub 2023 Aug 14. Mol Metab. 2023. PMID: 37586657 Free PMC article.
169 results